
Schrödinger
A computational platform transforming therapeutics and materials discovery through physics-based modeling and AI.

Engineering better molecules using artificial intelligence for drug-like antibody design.

Chai Discovery leverages artificial intelligence to engineer superior molecules, specifically focusing on drug-like antibody design. Their platform, Chai-2, moves beyond simple binding affinity, aiming to design antibodies closer to becoming real therapeutics. The AI architecture likely involves deep learning models trained on extensive datasets of antibody sequences, structures, and binding affinities. This allows for de novo design against challenging targets with atomic precision. The value proposition centers around accelerating the drug discovery process, reducing the reliance on traditional, time-consuming methods. Use cases include designing antibodies for novel therapeutic targets, optimizing existing antibody candidates for improved efficacy and developability, and generating diverse antibody libraries for screening.
Chai Discovery leverages artificial intelligence to engineer superior molecules, specifically focusing on drug-like antibody design.
Explore all tools that specialize in predict molecular properties. This domain focus ensures Chai Discovery delivers optimized results for this specific requirement.
Explore all tools that specialize in target identification. This domain focus ensures Chai Discovery delivers optimized results for this specific requirement.
AI-driven generation of novel antibody sequences and structures from scratch, based on target protein information.
AI-powered optimization of antibody sequences to minimize immunogenicity and improve compatibility with the human immune system.
AI-guided optimization of antibody binding affinity to the target protein, enhancing therapeutic efficacy.
AI-driven assessment and improvement of antibody developability characteristics, such as solubility, stability, and manufacturability.
AI-powered design of antibodies that can bind to multiple targets simultaneously, enabling synergistic therapeutic effects.
Account Creation and Project Setup
Target Protein Upload and Definition
Selection of Design Parameters (e.g., affinity, specificity)
Launch AI-Driven Antibody Design
Review and Filter Generated Antibody Candidates
Download Antibody Sequences and Structural Data for Further Analysis and Experimental Validation
All Set
Ready to go
Verified feedback from other users.
"Praised for accelerating antibody design and improving developability, with some concerns about cost for smaller research groups."
Post questions, share tips, and help other users.

A computational platform transforming therapeutics and materials discovery through physics-based modeling and AI.

High-performance computational chemistry for exascale molecular modeling and simulation.

Accelerating drug discovery through physics-informed machine learning and quantum-accurate molecular simulation.